Wall Street Analysts Think BioMarin (BMRN) Could Surge 70.77%: Read This Before Placing a Bet

BioMarin Pharmaceutical (BMRN) closed the last trading session at $56.62, gaining 3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $96.69 indicates a 70.8% upside potential.The mean estimate comprises 26 short-term price targets with a standard deviation of $14.53. While the lowest estimate of $65.00 indicates a 14.8% increase from the current price level, the most optimistic ana ...